In situ gene transfer and suicide gene therapy of gastric cancer induced by N-ethyl-N'-nitro-N-nitrosoguanidine in dogs

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 1039-1049

  Matsukura, Norio ^a   Hoshino, Arichika ^a   Igarashi, Takehito ^a   Hasegawa, Hirokazu ^a   Okino, Tetsuya ^a   Onda, Masahiko ^a   Iijima, Osamu ^b   Akiyama, Katsuhiko ^b   Goto, Takashi ^b   Takubo, Kaiyo ^c   Suzuki, Satoru ^a   Shimada, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b HISAMITSU PHARMACEUTICAL CO INC   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Adenovirus vector; Dog; Gene therapy; Lymph node; Suicide gene

Indexed keywords

ETHYLNITRONITROSOGUANIDINE; GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; DOG; ENDOSCOPIC BIOPSY; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; LYMPH NODE METASTASIS; MALE; MARKER GENE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; STOMACH CANCER; SUICIDE GENE; VIRUS GENE;

EID: 0032708466     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00852.x     Document Type: Article

References (25)

1. Anderson, W. F. Human gene therapy. Science, 256, 808-813 (1992).
2. Miller, A. D. Human gene therapy comes of age. Nature, 357, 455-460 (1992).
3. Anderson, W. F. Gene therapy for cancer. Hum. Gene Ther., 5, 1-2 (1994).
4. Mastrangelo, M., Berd, D., Nathan, F. E. and Lattime, E. C. Gene therapy for human cancer: an essay for clinicians. Semin. Oncol., 23, 4-21 (1996).
5. Fearson, E. R. and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61, 759-767 (1990).
6. Harris, C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst., 88, 1442-1455 (1996).
7. Freeman, S. M., Whartenby, K. A., Freeman, J. L., Abboud, C. N. and Marrogi, A. J. In situ use of suicide genes for cancer therapy. Semin. Oncol., 23, 31-45 (1996).
8. Tanaka, T., Kanai, F., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Shiratori, Y., Lan, K.-H., Isitobi, M. and Omata, M. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. Cancer Res., 56, 1341-1345 (1996).
9. Tanaka, T., Kanai, F., Lan, K.-H., Ohashi, M., Shiratori, Y., Yoshida, Y., Hamada, H. and Omata, M. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. Biochem. Biophys. Res. Commun., 231, 775-779 (1997).
10. Freeman, S. M., Abboud. C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L. and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53, 5274-5283 (1993).
11. Yamamoto, S., Suzuki, S., Hoshino, A., Akimoto, M. and Shimada, T. Herpes simplex virus thymidine kinase/ ganciclovir-mediated killing of tumor cell induced tumor-specific cytotoxic T cells in mice. Cancer Gene Ther., 4, 91-96 (1997).
12. Harris, J. D., Gutierrez, A. A., Hurst, H. C., Sikora, K. and Lemoine, N. R. Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther., 1, 170-175 (1994).
13. Sasajima, K., Kawachi, T., Sano, T., Sugimura, T., Shimozato, Y. and Shirota, A. Esophageal and gastric cancers with metastases induced in dogs by N-ethyl-N′-nitro-N-nitrosoguanidine. J. Natl. Cancer Inst., 58, 1789-1794 (1977).
14. Kurihara, M. Inducement of canine gastric cancer by N-ethyl-N′-nitro-N-nitrosoguanidine (ENNG). Gastric Cancer, 1, 95-103 (1998).
15. Kotani, H., Newton, P. B., III, Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F. and McGarrity, G. J. Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther., 5, 19-28 (1994).
16. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C. and Saito, I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA, 93, 1320-1324 (1996).
17. Kanegae, Y., Makimura, M. and Saito, I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol., 47, 157-166 (1994).
18. Sambrook, J., Fritsch, E. F. and Maniatis, T. "Molecular Cloning, a Laboratory Manual," 2nd Ed. (1989). Plainview, Cold Spring Harbor Laboratory, NY.
19. Japanese Research Society for Gastric Cancer. "Japanese Classification of Gastric Carcinoma," English Ed. (1995). Kanehara & Co., Ltd., Tokyo.
20. Roth, J. A., Nguyen, D., Lawrence, D. D., Kemp. B. L., Carrasco, C. H., Ferson, D. Z., Hong, W. K., Komaki, R., Lee, J. J., Nesbitt, J. C., Pisters, K. M., Putnam, J. B., Schea, R., Shin, D. M., Walsh. G. L., Dolormente, M. M., Han, C. I., Martin, F. D., Yen, N., Xu, K., Stephens, L. C., McDonnell, T. J., Mukhopadhyay, T. and Cai, D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2, 985-991 (1996).
21. Blasé, M., Blankenstein, T., Brenner, M., Cohen-Haguenauer, O., Gansbacher, B., Russell, S., Sorrentino, B. and Velu, T. Vectors in cancer therapy: how will they deliver? Cancer Gene Ther., 2, 291-297 (1995).
22. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M. and Dorken, B. Liver-associated toxicity of the HSV-tk/GCV approach and adenovirus vectors. Cancer Gene Ther., 4, 9-16 (1997).
23. van der Eb, M. M., Cramer, S. J., Vergouwe, Y., Schagen, F. H. E., van Krieken, J. H. J. M., van der Eb, A. J., Borel Rinkes, I. H. M., van der Velde, C. J. H. and Hoeben, R. C. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther., 5, 451-458 (1998).
24. Lan, K. H., Kanai, F., Shiratori, Y., Okabe, S., Yoshida, Y., Wakimoto, H., Hamada, H., Tanaka, T., Ohashi, M. and Omata, M. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology, 111, 1241-1251 (1996).
25. Onda, M. and Matsukura, N. Gene therapy for gastrointestinal tract cancer: prospects for combination treatment consisting of surgery and molecular surgery. Surg. Today, 27, 1099-1102 (1997).